Q32 Bio Newsroom

Express News | Q32 Bio Inc : Raymond James Initiates Coverage With Strong Buy Rating; Target Price $90

BreakingsOct 24 20:19

Oppenheimer Maintains Q32 Bio(QTTB.US) With Buy Rating, Raises Target Price to $80

Futu NewsOct 16 20:31 · Ratings

Q32 Bio To Reveal Phase 1 Clinical Trial Results For Tissue-Targeted Complement Inhibitor ADX-097 At The American Society Of Nephrology Kidney Week 2024

BenzingaOct 14 19:20

Q32 Bio Inc. Patent Woes: Navigating the Perilous Waters of Intellectual Property Disputes

TipRanksOct 1 14:03

Q32 Bio Analyst Ratings

BenzingaSep 11 20:51 · Ratings

Wells Fargo Initiates Q32 Bio at Overweight With $95 Price Target

MT NewswiresSep 11 19:34 · Ratings

Wells Fargo Initiates Q32 Bio(QTTB.US) With Buy Rating, Announces Target Price $95

Wells Fargo analyst Derek Archila initiates coverage on $Q32 Bio(QTTB.US)$ with a buy rating, and sets the target price at $95.According to TipRanks data, the analyst has a success rate of 45.6% and

Futu NewsSep 11 18:33 · Ratings

Q32 Bio to Participate in Upcoming September Investor Conferences

PR NewswireAug 29 18:59

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Maintains Target Price $60

Piper Sandler analyst Christopher Raymond maintains $Q32 Bio(QTTB.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 53.9%

Futu NewsAug 23 19:33 · Ratings

Piper Sandler Sticks to Their Buy Rating for Q32 Bio (QTTB)

TipRanksAug 23 19:07 · Ratings

Piper Sandler Maintains Q32 Bio(QTTB.US) With Buy Rating, Raises Target Price to $60

Piper Sandler analyst Christopher Raymond maintains $Q32 Bio(QTTB.US)$ with a buy rating, and adjusts the target price from $45 to $60.According to TipRanks data, the analyst has a success rate of 53.

Futu NewsAug 19 19:31 · Ratings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)

TipRanksAug 19 19:00 · Ratings

Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)

TipRanksAug 13 22:20 · Ratings

Q32 Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results.

BenzingaAug 9 02:23

Express News | Q32 Bio Inc : Piper Sandler Raises Target Price to $60 From $45

BreakingsAug 8 21:16

Q32 Bio's Cash, Cash Equivalents, And Short-term Investments Of $107.6M As Of June 30, 2024, Expected To Provide Financial Runway Through Four Phase 2 Clinical Milestones And Into Mid-2026

BenzingaAug 8 19:52

Q32 Bio Q2 2024 GAAP EPS $(1.42) Misses $(1.04) Estimate

BenzingaAug 8 19:52

Press Release: Q32 Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Dow JonesAug 8 19:38

Q32 Bio | 10-Q: Quarterly report

SECAug 8 19:14 · Announcements

Q32 Bio: Q2 Earnings Snapshot

Yahoo FinanceAug 8 19:04